Nicolau, D. P., Onyeji, C. O., Zhong, M., Tessier, P. R., Banevicius, M. A., & Nightingale, C. H. (2000). Pharmacodynamic Assessment of Cefprozil against Streptococcus pneumoniae: Implications for Breakpoint Determinations. American Society for Microbiology.
Chicago ZitierstilNicolau, David P., Cyprian O. Onyeji, Mingkang Zhong, Pamela R. Tessier, Mary Anne Banevicius, und Charles H. Nightingale. Pharmacodynamic Assessment of Cefprozil against Streptococcus Pneumoniae: Implications for Breakpoint Determinations. American Society for Microbiology, 2000.
MLA ZitierstilNicolau, David P., et al. Pharmacodynamic Assessment of Cefprozil against Streptococcus Pneumoniae: Implications for Breakpoint Determinations. American Society for Microbiology, 2000.